Patients with PRKN mutations on both alleles present with typical early-onset parkinsonism, including slow disease progression, positive levodopa responsiveness, absence of cognitive decline, resting tremor, rigidity, and levodopa-induced dyskinesia. Here, PRKN is linked to Parkinson disease.